{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:07:05Z","timestamp":1791050825846,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":5386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1093\/ajcn\/87.6.1981s","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T01:32:32Z","timestamp":1518831152000},"page":"1981S-1990S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["Role of n\u22123 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease"],"prefix":"10.1016","volume":"87","author":[{"given":"Terry A","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/ajcn\/87.6.1981S_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(78)91505-2","article-title":"Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?","volume":"2","author":"Dyerberg","year":"1978","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/87.6.1981S_bib2","first-page":"1","article-title":"Lipid metabolism and ischemic heart disease in Greenland Eskimos.","volume":"3","author":"Bang","year":"1980","journal-title":"Adv Nutr Res"},{"key":"10.1093\/ajcn\/87.6.1981S_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1753-4887.1986.tb07603.x","article-title":"Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis.","volume":"44","author":"Dyerberg","year":"1986","journal-title":"Nutr Rev"},{"key":"10.1093\/ajcn\/87.6.1981S_bib4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/ajcn\/28.9.958","article-title":"Fatty acid composition of the plasma lipids in Greenland Eskimos.","volume":"28","author":"Dyerberg","year":"1975","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/87.6.1981S_bib5","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/ajcn\/34.9.1752","article-title":"The effect of various intakes of \u03c9-3 fatty acids on the blood lipid composition in healthy human subjects.","volume":"34","author":"Bronsgeest-Schoute","year":"1981","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/87.6.1981S_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0026-0495(83)90226-3","article-title":"The comparative reductions of the plasma lipids and lipoproteins by dietary polyunsaturated fats: salmon oil versus vegetable oils.","volume":"32","author":"Harris","year":"1983","journal-title":"Metabolism"},{"key":"10.1093\/ajcn\/87.6.1981S_bib7","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJM198505093121902","article-title":"Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglyceridemia.","volume":"312","author":"Phillipson","year":"1985","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1093\/ajcn\/87.6.1981S_bib8","doi-asserted-by":"crossref","first-page":"1645S","DOI":"10.1093\/ajcn\/65.5.1645S","article-title":"n\u22123 fatty acids and serum lipoproteins: human studies.","volume":"65","author":"Harris","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/87.6.1981S_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2006.02.012","article-title":"Effects of \u03c9-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review.","volume":"189","author":"Balk","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1093\/ajcn\/87.6.1981S_bib10","series-title":"Evidence Report\/Technology Assessment No. 93 (Prepared by Tufts-New England Medical Center Evidence-based Practice Center under Contract No. 290-02-0022).","article-title":"Effects of \u03c9-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease.","author":"Balk","year":"2004"},{"key":"10.1093\/ajcn\/87.6.1981S_bib11","unstructured":"Reliant Pharmaceuticals, Liberty Corners, NJ. Data on file."},{"key":"10.1093\/ajcn\/87.6.1981S_bib12","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.296.15.1885","article-title":"Fish intake, contaminants, and human health: evaluating the risks and the benefits.","volume":"296","author":"Mozaffarian","year":"2006","journal-title":"JAMA"},{"key":"10.1093\/ajcn\/87.6.1981S_bib13","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0022-2275(20)38424-8","article-title":"Reduction of postprandial triglyceridemia in humans by dietary \u03c9-3 fatty acids.","volume":"29","author":"Harris","year":"1988","journal-title":"J Lipid Res"},{"key":"10.1093\/ajcn\/87.6.1981S_bib14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ajcn\/71.4.914","article-title":"Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n\u22123 fatty acids.","volume":"71","author":"Westphal","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/87.6.1981S_bib15","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1172\/JCI113806","article-title":"Dietary polyunsaturated fats of the w-6 and w-3 series reduce postprandial lipoprotein levels.","volume":"82","author":"Weintraub","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1093\/ajcn\/87.6.1981S_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ajcn\/58.1.68","article-title":"Fish oil reduces postprandial triglyceride concentrations without accelerating lipid emulsion removal rates.","volume":"58","author":"Harris","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/87.6.1981S_bib17","first-page":"617","article-title":"Postprandial triacylglycerolaemia: the effect of low-fat dietary treatment with and without fish oil supplementation.","volume":"50","author":"Roche","year":"1996","journal-title":"Eur J Clin Nutr"},{"key":"10.1093\/ajcn\/87.6.1981S_bib18","first-page":"765","article-title":"Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels.","volume":"50","author":"Agren","year":"1996","journal-title":"Eur J Clin Nutr"},{"key":"10.1093\/ajcn\/87.6.1981S_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00043798-199710000-00011","article-title":"Safety and efficacy of Omacor in severe hypertriglyceridemia.","volume":"4","author":"Harris","year":"1997","journal-title":"J Cardiovasc Risk"},{"key":"10.1093\/ajcn\/87.6.1981S_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0021-9150(98)00301-3","article-title":"Correlation of serum triglyceride and its reduction by w-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins.","volume":"143","author":"Pownall","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1093\/ajcn\/87.6.1981S_bib21","first-page":"69","article-title":"Fenofibrate for the treatment of type IV and V hyperlipoproteinemias: a double-blind, placebo-controlled multicenter US study.","volume":"11","author":"Goldberg","year":"1989","journal-title":"Clin Ther"},{"key":"10.1093\/ajcn\/87.6.1981S_bib22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0021-9150(99)00267-1","article-title":"Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses.","volume":"148","author":"Calabresi","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1093\/ajcn\/87.6.1981S_bib23","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1161\/01.ATV.20.8.1990","article-title":"ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype.","volume":"20","author":"Minihane","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1093\/ajcn\/87.6.1981S_bib24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/17460875.1.5.579","article-title":"Combination use of statins and \u03c9-3 fatty acids: an emerging therapy for combined hyperlipidemia.","volume":"1","author":"Hoskins","year":"2006","journal-title":"Future Lipidol"},{"key":"10.1093\/ajcn\/87.6.1981S_bib25","first-page":"544","article-title":"An \u03c9-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridemia.","volume":"85","author":"Durrington","year":"2001","journal-title":"Heart"},{"key":"10.1093\/ajcn\/87.6.1981S_bib26","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.clinthera.2007.07.018","article-title":"Efficacy and tolerability of adding prescription \u03c9-3 fatty acids 4 g\/d to simvastatin 40 mg\/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.","volume":"29","author":"Davidson","year":"2007","journal-title":"Clin Ther"},{"key":"10.1093\/ajcn\/87.6.1981S_bib27","series-title":"Lovaza\u00ae (omega 3 acid ethyl esters capsules) package insert.","year":"2007"},{"key":"10.1093\/ajcn\/87.6.1981S_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ajcn\/84.1.37","article-title":"Factorial study of the effect of n\u22123 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity.","volume":"84","author":"Chan","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/87.6.1981S_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.mol.0000236363.63840.16","article-title":"Why do \u03c9-3 fatty acids lower serum triglycerides?","volume":"17","author":"Harris","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"10.1093\/ajcn\/87.6.1981S_bib30","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11745-004-1333-0","article-title":"Mechanisms of regulation of gene expression by fatty acids.","volume":"39","author":"Nakamura","year":"2004","journal-title":"Lipids"},{"key":"10.1093\/ajcn\/87.6.1981S_bib31","doi-asserted-by":"crossref","first-page":"27i","DOI":"10.1016\/j.amjcard.2005.12.024","article-title":"Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids.","volume":"98","author":"Davidson","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1093\/ajcn\/87.6.1981S_bib32","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2337\/diabetes.51.8.2377","article-title":"Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.","volume":"51","author":"Chan","year":"2002","journal-title":"Diabetes"},{"key":"10.1093\/ajcn\/87.6.1981S_bib33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1172\/JCI19197","article-title":"Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production.","volume":"113","author":"Pan","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1093\/ajcn\/87.6.1981S_bib34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/mend.11.6.0007","article-title":"Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.","volume":"11","author":"Krey","year":"1997","journal-title":"Mol Endocrinol"},{"issue":"suppl 1","key":"10.1093\/ajcn\/87.6.1981S_bib35","first-page":"14","article-title":"Polyunsaturated fatty acid inhibition of fatty acid synthase transcription is independent of PPAR activation.","volume":"37","author":"Clarke","year":"1998","journal-title":"Z Ernahrungswiss"},{"key":"10.1093\/ajcn\/87.6.1981S_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1194\/jlr.M200282-JLR200","article-title":"Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance.","volume":"44","author":"Park","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1093\/ajcn\/87.6.1981S_bib37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ajcn\/66.2.254","article-title":"Influence of n\u22123 fatty acid supplementation on the endogenous activities of plasma lipases.","volume":"66","author":"Harris","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/87.6.1981S_bib38","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/ajcn\/53.3.638","article-title":"Postheparin lipolytic activity and plasma lipoprotein response to \u03c9-3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia.","volume":"53","author":"Nozaki","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/87.6.1981S_bib39","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0022-2275(20)30473-9","article-title":"Dietary long-chain n\u22123 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype.","volume":"43","author":"Khan","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1093\/ajcn\/87.6.1981S_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/ajcn\/80.1.45","article-title":"Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids.","volume":"80","author":"Park","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/87.6.1981S_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0955-2863(98)00094-1","article-title":"Omega-3 fatty acids alter lipoprotein subfraction distributions and the in vitro conversion of very low density lipoproteins to low density lipoproteins.","volume":"10","author":"Lu","year":"1999","journal-title":"J Nutr Biochem"},{"key":"10.1093\/ajcn\/87.6.1981S_bib42","doi-asserted-by":"crossref","first-page":"61i","DOI":"10.1016\/j.amjcard.2005.12.028","article-title":"Secondary prevention of coronary artery disease with omega-3 fatty acids.","volume":"98","author":"Jacobson","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1093\/ajcn\/87.6.1981S_bib43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n\u22123 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/87.6.1981S_bib44","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","article-title":"Early protection against sudden death by n\u22123 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.","volume":"105","author":"Marchioli","year":"2002","journal-title":"Circulation"},{"key":"10.1093\/ajcn\/87.6.1981S_bib45","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/87.6.1981S_bib46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11883-007-0011-x","article-title":"Beyond lipids: the role of omega-3 fatty acids from fish oil in the prevention of coronary heart disease.","volume":"9","author":"Jacobson","year":"2007","journal-title":"Curr Atherosclerosis Reports"},{"key":"10.1093\/ajcn\/87.6.1981S_bib47","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.amjcard.2006.11.021","article-title":"Expert opinion: omega-3 fatty acids and bleeding\u2014cause for concern?","volume":"99","author":"Harris","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1093\/ajcn\/87.6.1981S_bib48","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).JAMA285:2486\u201397.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1093\/ajcn\/87.6.1981S_bib49","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","article-title":"Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.","volume":"106","author":"Kris-Etherton","year":"2002","journal-title":"Circulation"},{"key":"10.1093\/ajcn\/87.6.1981S_bib50","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.106.174516","article-title":"AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291652323734X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291652323734X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/87\/6\/1981S\/23919406\/ajc006080s1981.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T13:09:39Z","timestamp":1685365779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291652323734X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S000291652323734X"],"URL":"https:\/\/doi.org\/10.1093\/ajcn\/87.6.1981s","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of n\u22123 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/ajcn\/87.6.1981S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}